By Priscila Mayumi Kashiwabara
3 de November de 2023
Kasznar Leonardos is recognized on the Lexology Legal Influencer 2023
We are honored to announce that three members of our team have been elected Lexology Legal Influencers 2023 in the Central and South America region.
Our partner, Priscila Kashiwabara, has been selected as the Lexology Legal Influencer for the second quarter of 2023 in matters related to Intellectual Property and in the third quarter in Healthcare and Life Sciences. Our partner, Felipe Monteiro, earned the title for the content published in the third quarter of the current year in Technology, Media, and Telecommunications, alongside our expert, Felipe Florentino, who also made it to the exclusive list for outstanding performance in the third quarter in Intellectual Property.
We are proud to have some of the most respected and influential professionals in the market, focused on producing quality content that showcases our expertise daily.
Last by Priscila Mayumi Kashiwabara
25 de August de 2026
Brazilian Patent and Trademark Office and Uruguay’s DNPI Launch Collaborative Patent Application Examination Project
On August 25, 2026, the Brazilian Patent and Trademark Office (INPI) announced the launch of a Collaborative Patent Application Examination Project in … Brazilian Patent and Trademark Office and Uruguay’s DNPI Launch Collaborative Patent Application Examination Project
14 de August de 2026
INPI and INDECOPI Launch Collaborative Patent Examination Project Focusing on Pharmaceuticals and Biotechnology
On August 11, 2026, the Brazilian Patent and Trademark Office (INPI) announced the launch of the Collaborative Patent Application Examination Project, developed … INPI and INDECOPI Launch Collaborative Patent Examination Project Focusing on Pharmaceuticals and Biotechnology
1 de July de 2026
INPI Ordinance No. 80/2026 and Second Medical Use Patents
INPI Ordinance No. 80/2026, published on June 30, 2026, in the Official Gazette No. 2895, revised Chapter 9 of the Guidelines for Examination … INPI Ordinance No. 80/2026 and Second Medical Use Patents